Simultaneous estimation of gabapentin and methylcobalamin in bulk and pharmaceutical dosage form by RP-HPLC
A simple, selective, linear, precise, and accurate RP-HPLC method was developed and validated for the simultaneous estimation of Gabapentin & Methylcobalamin from bulk and formulation. Chromatographic separation was achieved Isocratically on an Inertsil C18 column (150x4.6, 5µ particle size) using a mobile phase Buffer: Acetonitrile in the ratio of 60:40 v/v. The flow rate was 1.0 ml/min, effluents were detected at 264 nm and 10µl of sample was injected. Retention time of Gabapentin & Methylcobalamin was found to be 2.7 and 4.13 min respectively. Linearity of the method was in the concentration range of 25-150 µg for Gabapentin & 0.125-0.750 µg for Methylcobalamin. Percent recoveries obtained for both the drugs were 100.00%. The percentage RSD for precision of the method was found to be less than 2%. The method was validated according to the ICH guidelines. The method developed was successfully applied for the analysis of simultaneous estimation of Gabapentin & Methylcobalamin tablets and was fairly good in comparison with other methods.
Keywords: Gabapentin, Methylcobalamin, HPLC.
2) Sharma MC et al, Simultaneous Estimation and Validation of Gabapentin and Methylcobalamin in Tablet Dosage form: hydrotropic approach, Drug Invention Today, 2011; 3(6):95.
3) Baheti KG, Galande VR, Simultaneous Estimation of Gabapentin in the Presence of Methylcobalamin in Tablet by HPTLC Method, International journal of research in Pharmaceutical and Biomedical sciences, Jul-Sep 2011; 2(3).
4) Abdullatif HE, Khalil H.M., Colorimetric determination of Gabapentin in pharmaceutical formulation, J. Pharma. and Biomed. Anal, 2003.
5) Bharath BR, Shantha A., Malairajan P. et al. Simultaneous estimation and validation of Gabapentin and Methylcobalamin in combined dosage form by PR-HPLC, Indian Drugs, 2007; 44(10)L:784-788. 8. Beckett A. H. and Stenlake.
6) Galande R et al, UV VIS Spectrophotometric method for the estimation of Gabapentin & Mecobalamin in bulk & tablet, International Journal of Chemtech research, Jan – Mar 2010; 2(1):695-699
7) Lakshmi B et al, UV VIS Spectrophotometric method for the estimation of Gabapentin in formulations, The Experiment, August 2012; 2:84-92.
8) Goti PP, Patel PB, Development and validation of ratio derivative spectrophotometric method for simultaneous estimation of Gabapentin, Methylcobalamin and alpha lipoic acid in tablet formulation, Journal of Pharmacy research, june 2013; 6(6):
9) Saravanan V., Revathi R., Meera N. Method development and validation for the simultaneous estimation of lycopene and ubidecarenone by RP-HPLC in combined pharmaceutical dosage form. Journal of Drug Delivery and Therapeutics, 2016; 6(5):46-51.
10) Shashe Kumar P, Reddy R et.al. RP-HPLC method development and validation for simultaneous estimation of gabapentin and mecobalamine in tablet dosage form. IJPRA, 2014; 4(7):388-392.
11) Sumaiya H, Vani R et al, stability indicating method development and Validation of RP-HPLC method for simultaneous estimation of gabapentin and mecobalamine in bulk and its tablets; world journal of pharmacy and pharmaceutical sciences; 2014,3(12):1095-1106.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeÂ The Effect of Open Access).